Tom Mueller

All read papers (54)

RNA-programmed genome editing in human cells

Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J.

Elife · 2013

3.3/5

Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA

Muyzer G, de Waal EC, Uitterlinden AG.

Appl Environ Microbiol · 1993

2.0/5

Cluster analysis and display of genome-wide expression patterns

Eisen MB, Spellman PT, Brown PO, Botstein D.

Proc Natl Acad Sci U S A · 1998

2.3/5

A view on drug resistance in cancer

Vasan N, Baselga J, Hyman DM.

Nature · 2019

2.5/5

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P.

Nature · 1999

3.8/5

Ferroptosis: mechanisms, biology and role in disease

Jiang X, Jiang X, Stockwell BR, Conrad M.

Nat Rev Mol Cell Biol · 2021

3.5/5

The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells

Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, Lennon NJ, Livak KJ, Mikkelsen TS, Rinn JL.

Nat Biotechnol · 2014

3.0/5

Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system

Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE, Joung J, van der Oost J, Regev A, Koonin EV, Zhang F.

Cell · 2015

3.0/5

Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype

Kim D, Paggi JM, Park C, Bennett C, Salzberg SL.

Nat Biotechnol · 2019

3.3/5

Comprehensive molecular portraits of human breast tumours

Cancer Genome Atlas Network.

Nature · 2012

4.3/5

Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors

Anzalone AV, Koblan LW, Liu DR.

Nat Biotechnol · 2020

4.0/5

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E, Barlesi F, Kohlhäufl M, Arrieta O, Burgio MA, Fayette J, Lena H, Poddubskaya E, Gerber DE, Gettinger SN, Rudin CM, Rizvi N, Crinò L, Blumenschein GR, Antonia SJ, Dorange C, Harbison CT, Graf Finckenstein F, Brahmer JR.

N Engl J Med · 2015

2.8/5

Neuropathological stageing of Alzheimer-related changes

Braak H, Braak E.

Acta Neuropathol · 1991

4.5/5

Role of the microbiota in immunity and inflammation

Belkaid Y, Hand TW.

Cell · 2014

2.3/5

Shared and distinct transcriptomic cell types across neocortical areas

Tasic B, Yao Z, Graybuck LT, Smith KA, Nguyen TN, Bertagnolli D, Goldy J, Garren E, Economo MN, Viswanathan S, Penn O, Bakken T, Menon V, Miller J, Fong O, Hirokawa KE, Lathia K, Rimorin C, Tieu M, Larsen R, Casper T, Barkan E, Kroll M, Parry S, Shapovalova NV, Hirschstein D, Pendergraft J, Sullivan HA, Kim TK, Szafer A, Dee N, Groblewski P, Wickersham I, Cetin A, Harris JA, Levi BP, Sunkin SM, Madisen L, Daigle TL, Looger L, Bernard A, Phillips J, Lein E, Hawrylycz M, Svoboda K, Jones AR, Koch C, Zeng H.

Nature · 2018

3.3/5

The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions

Oughtred R, Rust J, Chang C, Breitkreutz BJ, Stark C, Willems A, Boucher L, Leung G, Kolas N, Zhang F, Dolma S, Coulombe-Huntington J, Chatr-Aryamontri A, Dolinski K, Tyers M.

Protein Sci · 2021

3.0/5

Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria

Gasiunas G, Barrangou R, Horvath P, Siksnys V.

Proc Natl Acad Sci U S A · 2012

2.8/5

Extracellular vesicles: exosomes, microvesicles, and friends

Raposo G, Stoorvogel W.

J Cell Biol · 2013

4.5/5

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD.

Nat Biotechnol · 2013

3.3/5

Differential expression analysis for sequence count data

Anders S, Huber W.

Genome Biol · 2010

3.8/5

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH.

Alzheimers Dement · 2011

3.8/5

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Love MI, Huber W, Anders S.

Genome Biol · 2014

3.5/5

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N.

Sci Signal · 2013

2.8/5

TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS.

Cancer Res · 2017

2.5/5

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee.

Genet Med · 2015

2.5/5

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG.

Science · 2003

2.3/5

Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers

Hilton IB, D'Ippolito AM, Vockley CM, Thakore PI, Crawford GE, Reddy TE, Gersbach CA.

Nat Biotechnol · 2015

4.3/5

Diversity of the human intestinal microbial flora

Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA.

Science · 2005

2.0/5

Post-transcriptional gene regulation by mRNA modifications

Zhao BS, Roundtree IA, He C.

Nat Rev Mol Cell Biol · 2017

4.3/5

Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells

Meyers RM, Bryan JG, McFarland JM, Weir BA, Sizemore AE, Xu H, Dharia NV, Montgomery PG, Cowley GS, Pantel S, Goodale A, Lee Y, Ali LD, Jiang G, Lubonja R, Harrington WF, Strickland M, Wu T, Hawes DC, Zhivich VA, Wyatt MR, Kalani Z, Chang JJ, Okamoto M, Stegmaier K, Golub TR, Boehm JS, Vazquez F, Root DE, Hahn WC, Tsherniak A.

Nat Genet · 2017

2.0/5

A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles

Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X, Gould J, Davis JF, Tubelli AA, Asiedu JK, Lahr DL, Hirschman JE, Liu Z, Donahue M, Julian B, Khan M, Wadden D, Smith IC, Lam D, Liberzon A, Toder C, Bagul M, Orzechowski M, Enache OM, Piccioni F, Johnson SA, Lyons NJ, Berger AH, Shamji AF, Brooks AN, Vrcic A, Flynn C, Rosains J, Takeda DY, Hu R, Davison D, Lamb J, Ardlie K, Hogstrom L, Greenside P, Gray NS, Clemons PA, Silver S, Wu X, Zhao WN, Read-Button W, Wu X, Haggarty SJ, Ronco LV, Boehm JS, Schreiber SL, Doench JG, Bittker JA, Root DE, Wong B, Golub TR.

Cell · 2017

3.0/5

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM.

Neuron · 2003

1.8/5

Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta

Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J.

Nature · 2000

2.3/5

Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity

Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, Zhang F.

Cell · 2013

2.5/5

Gene regulation by long non-coding RNAs and its biological functions

Statello L, Guo CJ, Chen LL, Huarte M.

Nat Rev Mol Cell Biol · 2021

3.0/5

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR.

Nature · 2016

3.8/5

Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation

Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen Y, Whitehead EH, Guimaraes C, Panning B, Ploegh HL, Bassik MC, Qi LS, Kampmann M, Weissman JS.

Cell · 2014

2.5/5

TIMER2.0 for analysis of tumor-infiltrating immune cells

Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS.

Nucleic Acids Res · 2020

2.5/5

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P.

Lancet Neurol · 2007

2.0/5

Search-and-replace genome editing without double-strand breaks or donor DNA

Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, Chen PJ, Wilson C, Newby GA, Raguram A, Liu DR.

Nature · 2019

2.8/5

MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens

Li W, Xu H, Xiao T, Cong L, Love MI, Zhang F, Irizarry RA, Liu JS, Brown M, Liu XS.

Genome Biol · 2014

4.3/5

Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection

Eyquem J, Mansilla-Soto J, Giavridis T, van der Stegen SJ, Hamieh M, Cunanan KM, Odak A, Gönen M, Sadelain M.

Nature · 2017

3.0/5

Reactive astrocyte nomenclature, definitions, and future directions

Escartin C, Galea E, Lakatos A, O'Callaghan JP, Petzold GC, Serrano-Pozo A, Steinhäuser C, Volterra A, Carmignoto G, Agarwal A, Allen NJ, Araque A, Barbeito L, Barzilai A, Bergles DE, Bonvento G, Butt AM, Chen WT, Cohen-Salmon M, Cunningham C, Deneen B, De Strooper B, Díaz-Castro B, Farina C, Freeman M, Gallo V, Goldman JE, Goldman SA, Götz M, Gutiérrez A, Haydon PG, Heiland DH, Hol EM, Holt MG, Iino M, Kastanenka KV, Kettenmann H, Khakh BS, Koizumi S, Lee CJ, Liddelow SA, MacVicar BA, Magistretti P, Messing A, Mishra A, Molofsky AV, Murai KK, Norris CM, Okada S, Oliet SHR, Oliveira JF, Panatier A, Parpura V, Pekna M, Pekny M, Pellerin L, Perea G, Pérez-Nievas BG, Pfrieger FW, Poskanzer KE, Quintana FJ, Ransohoff RM, Riquelme-Perez M, Robel S, Rose CR, Rothstein JD, Rouach N, Rowitch DH, Semyanov A, Sirko S, Sontheimer H, Swanson RA, Vitorica J, Wanner IB, Wood LB, Wu J, Zheng B, Zimmer ER, Zorec R, Sofroniew MV, Verkhratsky A.

Nat Neurosci · 2021

2.0/5

Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Sweeney MD, Sagare AP, Zlokovic BV.

Nat Rev Neurol · 2018

2.8/5

Complement and microglia mediate early synapse loss in Alzheimer mouse models

Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, Lemere CA, Selkoe DJ, Stevens B.

Science · 2016

2.3/5

TREM2 variants in Alzheimer's disease

Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J, Alzheimer Genetic Analysis Group.

N Engl J Med · 2013

3.5/5

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM, Goldberg RM, de la Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders RA, Eshleman JR, Vogelstein B, Diaz LA.

N Engl J Med · 2015

2.5/5

DNA targeting specificity of RNA-guided Cas9 nucleases

Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F.

Nat Biotechnol · 2013

3.8/5

Improving CRISPR-Cas nuclease specificity using truncated guide RNAs

Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK.

Nat Biotechnol · 2014

2.5/5

SCENIC: single-cell regulatory network inference and clustering

Aibar S, González-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, Rambow F, Marine JC, Geurts P, Aerts J, van den Oord J, Atak ZK, Wouters J, Aerts S.

Nat Methods · 2017

2.0/5

Generation of functional human pancreatic β cells in vitro

Pagliuca FW, Millman JR, Gürtler M, Segel M, Van Dervort A, Ryu JH, Peterson QP, Greiner D, Melton DA.

Cell · 2014

2.5/5

Predicting effective microRNA target sites in mammalian mRNAs

Agarwal V, Bell GW, Nam JW, Bartel DP.

Elife · 2015

3.8/5

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Schreiber RD, Old LJ, Smyth MJ.

Science · 2011

3.0/5

A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae

Sikorski RS, Hieter P.

Genetics · 1989

4.0/5